USP7 and Hao-Fountain syndrome: Additionally, both Sertraline and Astemizole proved to enhance the deubiquitinase activity of selected USP7 pathogenic mutants, and the antihistamine compound was also able to upregulate the enzyme in mutants associated with Hao–Fountain Syndrome (HAFOUS) in a cell-based assay.